Indication
Mood Disorders
14 clinical trials
18 products
2 drugs
Clinical trial
A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2022-09-23
Product
LY03010Clinical trial
A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia PatientsStatus: Completed, Estimated PCD: 2022-03-15
Product
Paliperidone palmitateProduct
Invega SustennaClinical trial
A Phase 2, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Oral Administration of Ganaxolone in Women With Postpartum DepressionStatus: Completed, Estimated PCD: 2019-07-05
Product
PlaceboProduct
GanaxoloneClinical trial
A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum DepressionStatus: Completed, Estimated PCD: 2019-05-10
Product
EndotoxinClinical trial
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)Status: Recruiting, Estimated PCD: 2028-02-01
Product
PsilocybinClinical trial
The Efficacy and Safety of Esketamine for Rapid Treatment of Depressive Episodes With Suicidal Ideation in Mood Disorders: A Multicenter, Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Product
EsketamineClinical trial
Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized PatientsStatus: , Estimated PCD: 2024-06-01
Product
Nitrous OxideProduct
Placebo gasClinical trial
An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in YouthStatus: Recruiting, Estimated PCD: 2025-01-01
Product
N-acetylcysteineClinical trial
Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWAREStatus: Completed, Estimated PCD: 2023-02-01
Product
AWARE interventionClinical trial
The Effects of Citalopram on the Brain's Response to FacesStatus: Not yet recruiting, Estimated PCD: 2025-10-31
Product
CitalopramDrug
VarlilumabClinical trial
Synaptic Imaging and Brain Network Activity Following Ketamine in Treatment Resistant DepressionStatus: Recruiting, Estimated PCD: 2023-08-31
Drug
KetamineProduct
MidazolamClinical trial
Assisted Animal Therapy in a French Intensive Care Unit (ICU): An Open Randomized StudyStatus: Terminated, Estimated PCD: 2022-08-24
Product
Nasal swab samplingProduct
Rectal swabClinical trial
Adjunctive Treatment With Pramipexole for Anhedonic Depression Symptoms in Depression - PRIME-PRAXOLStatus: Recruiting, Estimated PCD: 2026-12-01
Product
Pramipexole